Medline (MDLN) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Medline (MDLN) is Neutral.

The composite score behind that read is -0.08, weighing +0.34 of bullish evidence against -0.51 bearish.

Medline last closed at $35.80, +0.53% on the session.

Against the IVW growth benchmark the position is -0.39% over the forecast window.

The read is built from 12 underlying insights — 6 bullish and 6 bearish.

Agreement across those insights is 50%.

16 graded predictions for MDLN so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Medline in the 19th percentile on valuation and the 49th percentile on return on equity, where 100 is best.

Medline is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $46.82B.

StockMap tracks Medline as the 8th largest of the 133 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 67 Neutral, 61 Moderate Underperform, 4 Strong Underperform and 1 Moderate Outperform.

On that composite Medline ranks 30th of 133 in the group, against a group median of -0.21.